JPS5576865A - Azosin derivative*its pharmacologically acceptable salt and manufacture thereof* pharmaceutic composition of their active ingredients and treatment for mammal by its use - Google Patents

Azosin derivative*its pharmacologically acceptable salt and manufacture thereof* pharmaceutic composition of their active ingredients and treatment for mammal by its use

Info

Publication number
JPS5576865A
JPS5576865A JP14715579A JP14715579A JPS5576865A JP S5576865 A JPS5576865 A JP S5576865A JP 14715579 A JP14715579 A JP 14715579A JP 14715579 A JP14715579 A JP 14715579A JP S5576865 A JPS5576865 A JP S5576865A
Authority
JP
Japan
Prior art keywords
azosin
mammal
derivative
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14715579A
Other languages
Japanese (ja)
Inventor
Harutenshiyutain Yohanesu
Zatsutsuingaa Geruharuto
Baaruman Hainritsuhi
Ganzaa Fuorukaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of JPS5576865A publication Critical patent/JPS5576865A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
JP14715579A 1978-11-15 1979-11-15 Azosin derivative*its pharmacologically acceptable salt and manufacture thereof* pharmaceutic composition of their active ingredients and treatment for mammal by its use Pending JPS5576865A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782849472 DE2849472A1 (en) 1978-11-15 1978-11-15 Tetra:hydro-6-oxo-2,8a-methano-di:benzazocine derivs. - with central nervous, esp. analgesic and sedative, activity

Publications (1)

Publication Number Publication Date
JPS5576865A true JPS5576865A (en) 1980-06-10

Family

ID=6054689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14715579A Pending JPS5576865A (en) 1978-11-15 1979-11-15 Azosin derivative*its pharmacologically acceptable salt and manufacture thereof* pharmaceutic composition of their active ingredients and treatment for mammal by its use

Country Status (3)

Country Link
JP (1) JPS5576865A (en)
DE (1) DE2849472A1 (en)
HU (1) HU178555B (en)

Also Published As

Publication number Publication date
HU178555B (en) 1982-05-28
DE2849472A1 (en) 1980-06-19

Similar Documents

Publication Publication Date Title
NO784397L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PHTALAZIN-4-YL-ACTIC ACID DERIVATIVES
DE2861289D1 (en) Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds
HU174325B (en) Process for producing benzoic acid derivatives and pharmaceutical compositions containing them as active agents
PT65870B (en) Process for the preparation of a fungicidal composition containing a combination of active ingredients
GR61307B (en) Preparation process of pharmacologically active compounds
JPS5312860A (en) Novel halogenated 11azolyllbutane derivative and its salt* its preparation and fugicidal composition containing same as active ingredient
JPS5321163A (en) Novel azolyllcarboxylic acid derivative* its preparation and fungicidal composition containing same as active ingredient
JPS5581878A (en) Novel derivative of 33quinolinecarboxylic acid* its manufacture* its use as drug and pharmaceutic composition containing said derivative
DE2963572D1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
GB2006187B (en) Pharmaceutical compositions comprising heterocyclic compounds as active ingredient
HU178439B (en) Herbicide compositions containing tetrahydrofuril-ether derivatives and process for producing these compounds as active agents
GR60810B (en) Preparation process of pharmaceutically active compounds
JPS5545684A (en) Novel derivative of 33*aminoethyl*phenol and its salt*their manufacture*their use as drug and pharmaceutic composition containing them
HU174927B (en) Process for producing 1-benzazoalkyl-4-substituted-piperidine derivatives and pharmaceutical compositions containing them as active agents
IT1140529B (en) COMPOSITIONS TO BE USED AS COSMETICS AND PROCEDURE FOR THE PREPARATION OF THEIR ACTIVE INGREDIENTS
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
JPS54117483A (en) Novel derivative of 33phenyltetrahydropyridine and its salt*their manufacture*their application as drug and pharmaceutical composition containing them
JPS5587786A (en) Novel manufacture of piperidylindole derivative* obtained novel compound and its salt*their use as drug and pharmaceutic composition containing them
JPS5346931A (en) Organismmkilling active composition containing aryl hydrazone derivative as effective ingredient and process for preparation thereof
JPS5576865A (en) Azosin derivative*its pharmacologically acceptable salt and manufacture thereof* pharmaceutic composition of their active ingredients and treatment for mammal by its use
NO142525C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE ISOTIOR INGREDIENTS
AR219370A1 (en) PROCEDURE FOR THE PREPARATION OF DETOXIFIED PHARMACEUTICAL COMPOSITIONS OF CYTHOSTATICALLY ACTIVE ALKYLATING AGENTS
HU174097B (en) Process for producing 3-amino-2-hydroxypropane-disubstituted phenolether derivatives and pharmaceutical compositions containing them as active agents
JPS5481248A (en) Novel derivative and salt of 5hhbenzocycloo heptenee77amine*their manufacture and pharmaceutical composition containing them
IT8024152A0 (en) DERIVATIVES OF 1,1,2-TRIFENYLPROPANE AND 1,1,2-TRIFENYLPROPENE, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS